Related references
Note: Only part of the references are listed.The role of Human leukocyte antigen class I on patient survival in Gastrointestinal cancers: a systematic review and meta- analysis
Hadis Najafimehr et al.
SCIENTIFIC REPORTS (2020)
Tuning of NK-Specific HLA-C Expression by Alternative mRNA Splicing
Frederick J. Goodson-Gregg et al.
FRONTIERS IN IMMUNOLOGY (2020)
Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy
Bruna C. Bertol et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)
Immune crosstalk in cancer progression and metastatic spread: a complex conversation
Hannah Garner et al.
NATURE REVIEWS IMMUNOLOGY (2020)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-High
Sumit Middha et al.
JCO PRECISION ONCOLOGY (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor et al.
CANCER CELL (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
Natalia Aptsiauri et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Expression of HLA-DQA1 and HLA-DQB1 genes in B lymphocytes, monocytes and whole blood
M. Zajacova et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2018)
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Quirin Hammer et al.
NATURE IMMUNOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Genetic Mechanisms of Immune Evasion in Colorectal Cancer
Catherine S. Grasso et al.
CANCER DISCOVERY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
Francisco Perea et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Plasma human leukocyte antigen-G (HLA-G) in patients with thyroid cancer
Murat Akin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2017)
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder et al.
PLOS MEDICINE (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity
Valsamo Anagnostou et al.
CLINICAL CANCER RESEARCH (2017)
Atypical responses in patients with advanced melanoma, lung cancer, renal-cell carcinoma and other solid tumors treated with anti-PD-1 drugs: A systematic review
Paola Queirolo et al.
CANCER TREATMENT REVIEWS (2017)
Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment
Frederick S. Varn et al.
CANCER RESEARCH (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
Frederick S. Varn et al.
NATURE COMMUNICATIONS (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
R. Dummer et al.
ANNALS OF ONCOLOGY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Sachet A. Shukla et al.
NATURE BIOTECHNOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
The ins and outs of MHC class II-mediated antigen processing and presentation
Paul A. Roche et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
E. C. M. Zeestraten et al.
BRITISH JOURNAL OF CANCER (2014)
HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC
Jian Ming Hu et al.
EPIGENETICS (2014)
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2014)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement
Liza C. Villaruz et al.
CLINICAL CANCER RESEARCH (2013)
Structural characteristics of HLA-DQ that may impact DM editing and susceptibility to type-1 diabetes
Zemin Zhou et al.
FRONTIERS IN IMMUNOLOGY (2013)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue
P. Saenz-Lopez et al.
TISSUE ANTIGENS (2010)
The Immunological Genome Project: networks of gene expression in immune cells
Tracy S. P. Heng et al.
NATURE IMMUNOLOGY (2008)
HLA-G: from biology to clinical benefits
Edgardo D. Carosella et al.
TRENDS IN IMMUNOLOGY (2008)
Inferring activity changes of transcription factors by binding association with sorted expression profiles
Chao Cheng et al.
BMC BIOINFORMATICS (2007)
Cellular co-localization of intron-4 containing mRNA and HLA-G soluble protein in melanoma analyzed by fluorescence in situ hybridization
Deborah Sangrouber et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Levels of soluble HLA-I and b2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy
M. Albitar et al.
LEUKEMIA (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer
T So et al.
CANCER RESEARCH (2005)
An update of the HLA genomic region, locus information and disease associations: 2004
T Shiina et al.
TISSUE ANTIGENS (2004)
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas
Y Nie et al.
CARCINOGENESIS (2001)
Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles
S Chaudhuri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
NK cell recognition of non-classical HLA class I molecules
M López-Botet et al.
SEMINARS IN IMMUNOLOGY (2000)
Share Paper
